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Summary
Removal of TRF2, a telomere shelterin protein, recapitulates
key aspects of telomere attrition including the DNA-damage
response and cell-cycle arrest [1]. Distinct from the response
of proliferating cells to loss of TRF2 [2, 3], in rodent noncy-
cling cells, TRF2 inhibition promotes differentiation and
growth [4, 5]. However, themechanism that couples telomere
gene-silencing features [6–8] to differentiation programs has
yet to be elucidated. Herewedescribe an extratelomeric func-
tion of TRF2 in the regulation of neuronal genes mediated by
the interaction of TRF2 with repressor element 1-silencing
transcription factor (REST), a master repressor of gene
networks devoted to neuronal functions [9–12]. TRF2-REST
complexes are readily detected by coimmunoprecipitation
assays and are localized to aggregated PML-nuclear bodies
in undifferentiated pluripotent human NTera2 stem cells.
Inhibition of TRF2, either by a dominant-negative mutant
or by RNA interference, dissociates TRF2-REST complexes
resulting in ubiquitin-proteasomal degradation of REST.
Consequentially, REST-targeted neural genes (L1CAM, b3-
tubulin, synaptophysin, and others) are derepressed, result-
ing in acquisition of neuronal phenotypes. Notably, selective
damage to telomeres without affecting TRF2 levels causes
neither REST degradation nor cell differentiation. Thus, in
addition to protecting telomeres, TRF2 possesses a novel
role in stabilization of REST thereby controlling neural tumor
and stem cell fate.
Results and Discussion
Telomere repeat factor 2 (TRF2) is essential for telomere integ-
rity [1]. To investigate whether TRF2 is also involved in epige-
netically regulating neuronal differentiation (cessation of cell
division, the expression of neuron-specific genes, and the out-
growth of neurites), we first expressed a dominant-negative
mutant of TRF2 (DN-TRF2, also known as TRF2DBDM) [2] in hu-
man SH-SY5Y neuroblastoma and NTera2 cells, a pluripotent
embryonal carcinoma stem cell line. Cells expressing DN-
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5These authors contributed equally to this workTRF2 exhibited neuron-like morphology with extension of neu-
rite processes in SH-SY5Y cells (Figure 1B) and an enrichment
of the neuronal marker b3 tubulin [13] in NTera2 cells (Fig-
ure 1A). A significant increase of total neurite length occurred
and was maintained for at least 15 days in cells expressing
DN-TRF2 compared to vector-controls (Figure 1D). Similarly,
selective depletion of endogenous TRF2 with shRNA interfer-
ence promoted neurite outgrowth (Figure 1E; Figure S3A avail-
able online). These results from inhibition of TRF2 by two inde-
pendent approaches suggest that TRF2 is required for the
maintenance of neural progenitors and stem cells in an undif-
ferentiated state. Thus, we further examined the effects of
overexpression of wild-type (WT) TRF2 in SH-SY5Y cells. As
expected, stable expression of WT-TRF2 prevented neurite
outgrowth upon exposure to terminal differentiation reagents
[14] (Figure S1A). In addition, TRF2 inhibition-induced neurite
elongation was coupled to cell-cycle arrest, whereas the effect
of WT-TRF2 on cell-cycle progression from at least six differ-
ent clones was transient and returned to levels of vector-trans-
fected control cells within 2 weeks (Figures S2A and S2B).
To understand the molecular basis of the cellular actions of
DN-TRF2, we initially performed an unbiased gene-array anal-
ysis to evaluate gene-expression changes resulting from inhi-
bition of TRF2 in SH-SY5Y cells. Upon TRF2 inhibition, 61
genes were significantly affected. The distribution of these
genes in the genome was scattered among chromosomes
with no obvious relationship to telomere location (Table S1).
This suggests that modulation of gene expression by TRF2
dysfunction is unlikely to involve a telomere positional effect,
in which telomeres are capable of exerting a silencing effect
on adjacent genes [6]. Notably, gene ontology analysis indi-
cated that 34% of the genes upregulated in response to DN-
TRF2 expression were involved in functions of differentiated
neurons (Figure S2C and Table S1).
REST is a master repressor that negatively regulates a net-
work of neuronal genes by binding to a conserved 23 bp motif
known as repressor element 1 (RE1) [9]. Several hundred po-
tential REST target genes have been identified, including
many involved in excitability, synaptic plasticity, cell adhesion,
and neurotrophic signaling [10, 11]. Because TRF2 inhibition
induced the expression of many genes associated with neuro-
nal functions, we explored a potential role for REST in this pro-
cess by coexpressing both DN-TRF2 and REST in SH-SY5Y
cells. Overexpression of REST prevented DN-TRF2-induced
neurite outgrowth (Figure 1C), suggesting that REST blocks
the ability of DN-TRF2 to induce differentiation. The latter ob-
servation prompted us to investigate whether TRF2 and REST
coexit in a functional complex in human pluripotent stem cells
before and after exposure to the differentiation stimuli. In un-
differentiated NTera2 cells, endogenous TRF2 and REST
were concentrated in numerous nuclear foci (Figure 2A). The
majority of TRF2 and REST double-positive foci were distinc-
tively colocalized in PML-nuclear body (PML-NB) aggregates.
In contrast, differentiated NTera2 cells (b3 tubulin-positive)
exhibited diffuse nuclear TRF2 and REST immunoreactivities,
with little or no concentration in PML-NB. Consistent with
these observations, REST protein in NTera2 cells was de-
creased after 28 days of differentiation (Figure 2B). These
Current Biology Vol 18 No 19
1490Figure 1. Inhibition of TRF2 Promotes Neuronal Differentiation
(A) NTera2 cells stably expressing either empty vector or dominant-negative (DN)-TRF2 were exposed to PA6 cell-conditioned differentiation medium for
21 days. The representative micrographs show b3 tubulin immunoreactivity (a neural marker) (red) and DAPI staining (blue), and the graph shows the
percentage of b3 tubulin-positive cells from 10 randomly chosen fields (n = 3, error bars 6 SE). **p < 0.005 compared to the vector value.
(B and C) Total neurite length was measured in SH-SY5Y-expressing GFP vector, DN-TRF2 (with GFP reporter), and in combination with flag-REST.
The representative micrographs and the graph show the GFP-positive processes and average of total neurite length (65–100 cells, n = 3), respectively.
**p < 0.0001 compared DN-TRF2 to the vector, *p < 0.001 compared either flag-REST to vector, or flag REST plus DN-TRF2 to DN-TRF2. Scale bars represent
20 mm.
(D) SH-SY5Y cells stably transfected with either empty vector or DN-TRF2 for 10 days were stained for the senescence-associated b-galactosidase
(SA-bGal). The arrow points to long neurites of differentiated cells and the arrowheads point to SA-bgal-positive (blue) cells. *p < 0.001 (40–48 cells, n = 4).
(E) SH-SY5Y cells expressing a TRF2 shRNA vector or empty vector were selected with 1 mg/ml puromycin for 10 days and were then stained for SA-bgal.
*p < 0.01 (60–100 cells, n = 4).results agree with recent reports that degradation of REST is
required for differentiation of stem cells into neurons [9, 12].
Next, we asked whether inhibition of TRF2 mimics the ef-
fects of differentiation medium on the subcellular localization
of TRF2 and REST. Overexpression of WT-TRF2 resulted in
increased numbers of nuclear foci of REST and TRF2 that co-
localized in PML-NB. In contrast, overexpression of DN-TRF2
resulted in decreased localization of TRF2 and REST in PML-
NB and a diffuse distribution of these proteins throughout
the nucleus, although a few TRF2 and REST foci were present
(Figure 2C).
PML-NB are critical for varied cellular functions including
DNA transcription/repair, apoptosis/senescence, and tumor
suppression. By orchestrating the recruitment of the ubiqui-
tin-proteasome system [15] or the small ubiquitin-like modifier(SUMO)-ylation system [16, 17], PML-NB play a key role in
regulating nuclear proteins dynamics. The association of
SUMOylated TRF2 with PML-NB is observed in a subtype of
telomerase-negative ALT (alternative lengthening of telomeres)
cells [18]. Moreover, early totipotent embryos also exhibit high
levels of ALT-like activity reminiscent of pluripotent human
cancer cells [19]. Consistently, we observed a more extended
association between REST, TRF2, and PML-NB in pluripotent
NTera2 cells compared to SH-SY5Y neuroblastoma cells (data
not shown).
Recent evidence demonstrates that SCFb-TRCP, an E3 ubiq-
uitin ligase, is responsible for REST degradation during neuro-
nal differentiation [12]. However, the regulatory factor that pre-
vents REST from being degraded by the ubiquitin-proteasome
system is unknown. To further characterize the interaction of
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1491Figure 2. TRF2 and REST Are Concentrated in PML-Nuclear Bodies in Undifferentiated ES Cells and Are Displaced from Those Sites in Response to
Neuronal Differentiation Signals or to TRF2 Inhibition
(A) Representative confocal micrographs show that REST (green), TRF2 (red), and PML-NB (purple) are colocalized in nuclear foci in undifferentiated NTera2
cells, but not in NTera2 cells being differentiated into b3 tubulin-positive neuron upon exposure to conditioned medium for 28 days. Scale bars represent
5 mm. Large arrows point to examples of foci containing REST, TRF2, and PML. The small arrow points to PML- and TRF2-positive foci exhibiting little or no
REST immunoreactivity. **p < 0.005 (50–75 cells per culture, n = 4).
(B) Lysates from undifferentiated and differentiated NTera2 cells were analyzed by immunoblots with antibodies against the indicated proteins.
(C) Numerous nuclear foci of REST and TRF2 are colocalized in PML-NB in NTera2 cells expressing WT-TRF2 (top). The concentration of REST and TRF2 in
PML-NB was markedly reduced in NTera2 cells expressing DN-TRF2 (bottom). Large arrows and small arrowheads point to examples of foci with or without
the association of REST, TRF2, and PML, respectively. Scale bars represent 5 mm. **p < 0.005 (50–75 cells per culture, n = 4).TRF2 with REST, we performed a reciprocal coimmunoprecipi-
tation analysis with whole-cell lysates of NTera2 cells (data not
shown) and HeLa cells by using antibodies against TRF2 and
REST proteins. The REST and TRF2 immunoactivities were
readily detected in their reciprocal immunoprecipitates, sug-
gesting that endogenous TRF2 and REST interact (Figure 3A).
We also observed that the interaction of REST with TRF2 in
the nucleus is enhanced by expressing WT-TRF2 and notice-
ably reduced by expressing DN-TRF2 (Figure 3B). We next de-
termined which region of the TRF2 protein interacts with REST.
Lysates from Cos-7 cells, expressing GST alone or GST fused
either to full-length TRF21-500 or to three different TRF2 trun-
cated mutants, were subjected to GST pull-down analysis. Co-
precipitation of endogenous REST was achieved with either
GST-TRF21-500 or GST-TRF45-446, but not with GST-TRF22-68
or GST-TRF2447-500 (Figure 3C), indicating that both WT-TRF2
and DN-TRF2 bind REST.
DN-TRF2 expression reduced REST protein levels in nuclear
or whole-cell extracts (Figures 3B and 3D). We therefore tested
the possibility that TRF2 inhibition facilitates REST degradation
via the ubiquitin-proteasome pathway. Upon loss of TRF2,
REST protein from its immunoprecipitates was graduallyreduced (Figure 3D). However, after treatment with the protea-
some inhibitor MG132, this reduction was completely pre-
vented at post-transfection day 2 but was partially restored
by post-transfection day 5. Moreover, the slower migrating
species of REST was associated with an increase of ubiquiti-
nated proteins in the same molecular-weight range in HeLa
cell coexpressing HA-tagged DN-TRF2 and Myc-tagged ubiq-
uitin after MG132 treatment (Figure 3E). These results sug-
gested that polyubquitin attachment to REST is increased in
response to loss of TRF2. Consistently, DN-TRF2 expression
in SH-SY5Y cells also caused a significant decrease in REST
levels within 2 days (Figure S3B), which could be rescued by
blocking proteasome activity. Nevertheless, upon TRF2 inhibi-
tion, p53 levels were increased, whereas REST levels were de-
creased (Figure S3B), indicating that DN-TRF2 has a selective
effect on REST degradation. In contrast, elevation of TRF2 in
SH-SY5Y cells attenuated REST depletion during the course
of neuronal differentiation (Figure S1B).
Because conjugation of proteins to lys48-linked polyubiqui-
tin chains is a common signal for proteasomal degradation, we
next investigated whether DN-TRF2 promotes the binding of
Lys48-linked ubiquitin chains to REST. The REST conjugation
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1492Figure 3. REST Binds Both WT-TRF2 and DN-TRF2, and Binding to DN-TRF2 Is Associated with REST Degradation via the Ubiquitin-Proteasome Pathway
(A) HeLa cell extracts were coimmunoprecipitated reciprocally with polyclonal antibodies to either REST or TRF2. Input protein (120 mg) and immunopre-
cipitates were subjected to immunoblot analysis with indicated antibodies.
(B) Nuclear extracts from HeLa cells were immunoprecipitated with a polyclonal antibody to REST and blots were probed with the indicated antibodies.
Equal loading for input proteins was evaluated by ponceau S (Pon.S) stain.
(C) GST fusion proteins containing full-length hTRF2, amino acids 2–68 of hTRF2 (basic region), amino acids 45–446 of hTRF2 (DN-TRF2), or amino acids
447–500 of hTRF2 (myb domain) were expressed in Cos-7 cells. Cells were subjected to GST pull-down and the precipitates were then analyzed by immu-
noblot with antibodies against REST and GST. A schematic representation of the domains in human TRF2 protein is shown at the bottom.
(D) HeLa cells expressing vector or DN-TRF2 for 2 or 5 days were treated without (2) or with (+) the proteasome inhibitor MG132 (10 mM) for 5 hr. Cell extracts
were subjected to immunoprecipitation with a REST antibody and blots were probed with the indicated antibodies.
(E) HeLa cells were cotransfected with either HA-tagged WT-TRF2 or HA-tagged DN-TRF2 in combination with Myc-tagged ubiquitin, then treated without
(2) or with (+) 10 mM MG132 for 5 hr. Cell extracts were subjected to immunoprecipitation with anti-HA affinity matrix. REST immunoblot was reprobed with
ubiquitin antibody. Arrows point to slow migration species of REST. *DN-TRF2 overlays with IgG heavy chain.
(F) HeLa cells were cotransfected with either HA-tagged wild-type ubiquitin (HA-UB/WT) or an ubiquitin mutant (HA-UB/K48), in combination with either
WT-TRF2 or DN-TRF2. Ubiquitin-conjugated proteins from cell extracts were captured with anti-HA affinity matrix and were subjected to immunoblot
analysis with REST antibody.to Lys48-linked ubiquitin was enhanced in cells coexpressing
DN-TRF2 (Figure 3F) with a HA-tagged ubiquitin mutant in
which all lysine residues except Lys48 were mutated to argi-
nine (HA-UB/K48) [12, 20] (Figure 3F). In contrast, expression
of WT-TRF2 reduced the conjugation of ubiquitin to REST
(Figures 3E and 3F). These results suggest that loss of TRF2
expedites lys48-linked polyubiquitination and proteasomal
degradation of REST and that the interaction of TRF2 with
REST maintains the stability of REST.
We next asked whether the reduction of REST levels in
response to TRF2 inhibition was directly responsible for the
observed changes in neural-specific genes. Analysis of the
DN-TRF2 target genes for the consensus REST binding se-
quence (NTYAGMRCCNNRGMSAG) [10] revealed that 12 out
of 61 genes contained at least one putative RE1 element within
50 kb of the transcriptional start site (Table S1, Figure S2C).
To further validate the differentiation-inducing effect of
TRF2 inhibition on bona fide REST target genes, SH-SY5Y cells
were infected with adenovirus expressing DN-TRF2, WT-
TRF2, or control (b-galactosidase) for 5 days, and RESTbinding was measured via chromatin immunoprecipitation
(ChIP). We found that REST bound to 9 of the 14 tested RE1 el-
ements, but not to any of the 6 promoters. Expression of DN-
TRF2 for 5 days reduced REST binding at most, if not all, loci
tested (Figure 4A). REST binding was detected at neuronal
gene loci (BDNF, L1CAM, miR-124a2, SCG10, SCN3A, synap-
tophysin, LSAMP, and synapsin), suggesting a direct role of
REST in regulation of these genes, including one microarray
target (b3-tubulin). But REST binding was not detected at the
predicted RE1 elements of two other microarray targets
(GATA3 andGAP43), suggesting that they were regulated indi-
rectly by REST in the system we tested. The observed REST
binding was 5 to 45 times higher than the background from
ChIP with control IgG (data not shown), suggesting that the
binding was specific.
We next performed quantitative RT-PCR and immunoblot
analysis to confirm that reduction of REST binding via TRF2
inhibition results in derepression of REST target genes. Rela-
tive mRNAs levels of several REST target genes including
L1CAM, SNAP25, synaptophysin, synapsin 1, and SCN3A
TRF2 and REST in Neural Cell Differentiation
1493Figure 4. Evidence for Telomere-Independent Inhibition of REST Degradation and Repression of Neuronal Genes and Cell Differentiation by TRF2
(A) Chromatin immunoprecipitation was used to measure REST binding in SH-SY5Y cells infected with adenovirus bearing DN-TRF2, WT-TRF2, or control
(b-galactosidase) for 5 days. Binding to each locus was determined relative to the input DNA. RE1 elements (RE1) and promoters (p) were tested. Binding to
control IgG averaged 0.0049% 6 0.0045%. This experiment is representative of three independent replicates.
(B) Real-time RT-PCR measurements of mRNA from SH-SY5Y cells that had been infected for 6 days with adenovirus bearing either DN-TRF2 or b-galac-
tosidase (control). The relative expression level of REST target genes was normalized against GAPDH and control (n = 3, error bars 6 SD). This result is
representative of three independent experiments.
(C) SH-SY5Y cells were exposed to either 40 mM of T-oligo or the complementary antisense oligonucleotide (AS). Cells treated with both oligos for 8 days
exhibited morphologies characteristic of undifferentiated cells (left). Arrowheads point to SA-bgal-positive cells. Scale bar represents 50 mm. Naive SH-SY5Y
cells (control) and cells were treated with T-oligo or AS-oligo for 2 days. Cell lysates were subjected to immunoblot analysis via antibodies against the
indicated proteins.
(D) Model: In human neural progenitors and pluripotent stem cells, the formation of TRF2-REST complex stabilizes REST in PML-NB, which silences neu-
ronal genes in heterochromatin region to suppress neuronal differentiation. Removal of TRF2 disassociates the TRF2-REST complex, facilitating polyubi-
quitination-proteasomal degradation of REST in a telomere-independent manner. Consequentially, REST-targeted neural genes are derepressed, resulting
in acquisition of neuronal phenotypes.were increased 2- to 4-fold in SH-SY5Y cells expressing DN-
TRF2 in comparison with control (Figure 4B). The expression
level of b3-tubulin was increased 1.5-fold (data not shown).
Within 3–5 days of adenoviral infection, SH-SY5Y cells ex-
pressing DN-TRF2, but not vector or WT-TRF2, also exhibited
increased levels of L1CAM, b3 tubulin, and GAP43 (Fig-
ure S3C), three well-known neurite outgrowth-regulating pro-
teins [21, 22]. Consistently, interfering with TRF2 expression
with shRNAs also resulted in REST degradation and derepres-
sion of the REST target gene L1CAM (Figure S3A).
We and others recently reported that in nondividing cells,
TRF2 dysfunction promotes differentiation/growth instead of
apoptosis [4, 5]. Thus, we predict that in proliferating neuronal
cells, the differentiation-inducing effects of TRF2 inhibition
may proceed independently of telomere damage responses
that typically involve the accumulation of gH2AX at the site
of DNA damage (Figure S3C) and cell senescence (Figures1D and 1E) [4]. To test this hypothesis, we employed a previ-
ously established telomere-decapping model, in which cells
are treated with a telomere G-strand oligonucleotide
(T-oligo) that mimicks the exposure of unprotected telomeres,
thus triggering DNA damage responses [23]. As expected,
cells treated with T-oligo, but not those treated with the
antisense (AS) oligo, exhibited features of a DNA damage re-
sponse including increased levels of gH2AX, p53, and p53
phosphorylated on serine 15 (Figure 4C). However, despite
these DNA damage responses, cells treated with T-oligo or
with AS-oligo TRF2 levels were unchanged and neither a
reduction in REST levels nor neurite outgrowth occurred
(Figure 4C). Similar results were obtained in neuroblastoma
cells treated with telomestatin, a chemical that causes
selective damage to telomeres [24] (Figure S4). Taken to-
gether, our data suggest that it is not telomere DNA damage
per se, but rather inhibition of TRF2 binding to REST that
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differentiation.
Our findings reveal a nontelomeric role for TRF2 in regulating
cell proliferation and differentiation through an interaction with
REST in PML-NB. The TRF2-REST complex may serve to pro-
tect REST from ubiquitin-proteasome degradation, thereby
maintaining neuronal progenitors and stem cells in an undiffer-
entiated stage. Removal of TRF2 not only induces telomere
DNA damage responses but also expedites proteolytic degra-
dation of REST in a telomere-independent manner, thereby
derepressing the expression of neuronal genes such as
L1CAM, b3-tubulin, BDNF, synaptophysin, and synapsin 1, re-
sulting in the morphological and functional differentiation of
neurons (Figure 4D). Our data support the telomere-looping-
effect theory from yeast studies [7, 8], in which telomeres are
juxtaposed with distal gene loci via a transient interaction be-
tween telomere-binding proteins and transcription factors,
permitting long-range repression. Although details of the mo-
lecular interactions remain to be established (e.g., whether the
TRF2 and REST interaction could bridge telomere region close
to REST targets [RE-1 locus]), our results provide evidence
that the telomere shelterin protein TRF2 is involved in the reg-
ulation of heterochromatin silencing domains by interaction
with the master neuronal repressor REST. These findings
expand an understanding of the function of a telomere-
associated proteins in the modulation of cell proliferation
and differentiation. Our findings from studies of human neuro-
blastoma cells further show that, by maintaining REST binding
at RE1 elements, TRF2 maintains tumor cells in a proliferative
state and that inhibition of the TRF2-REST interaction can
suppress cancer cell growth.
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